Skip to content

Quality of Life and Cancers in Nursing Homes

Quality of Life and Cancers in Nursing Homes

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03343210
Acronym
QUALICE
Enrollment
73
Registered
2017-11-17
Start date
2018-07-18
Completion date
2020-07-09
Last updated
2021-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Nurse's Role, Quality of Life

Brief summary

Quality of life (QOL) of nursing homes residents with cancer in France is not known. High prevalence of neurodegenerative diseases makes it difficult. It was found that oncological management is suboptimal among Poitevin territory residents. Publications report an inadequate management of symptoms of discomfort related to cancers. The multicentric study will comparate quality of life in patients with and without Cancers in nursing homes, including residents with neurodegenerative disease, using validated questionnaires. These questionnaires, as well as pain evaluation, will be carried out by a geriatric consultations' nurse.

Detailed description

Investigators will also make a descriptive inventory of the oncological care and support care in these patients, in order to evaluate the need for a specific oncogeriatric intervention. Quality of life and pain will be compared with a randomized residents control group, in each hospital.

Interventions

DIAGNOSTIC_TESTquality of life and pain measurement .

comparison of quality of life measurement in residents with cancer and in cancer-free residents, by a geriatric consultations'nurse

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Affiliated to the social security system * talking french language * Cancer group: All residents with a history of cancer, * Control group: residents without any history of cancer (same number of residents as in the cancer group), randomly selected in each nursing home, matched to age, sex, presence of dementia (mild or Moderate), and AGGIR dependancy scale

Exclusion criteria

* Severe dementia (MMS \<10/30) • Total disability to communicate

Design outcomes

Primary

MeasureTime frameDescription
quality of life measurement in patientsday 1Logsdon Quality Of Life Alzheimer Dementia scale if neurodegenerative disease or WHO-Quality Of Life- OLD scale if none

Secondary

MeasureTime frameDescription
pain levelday 1Simple Verbal Scale or Doloplus scale
independance lossday 1AGGIR(Autonomie Gérontologique et Groupes Iso-Ressources) scale
frequency of dementia3 monthsin ordrer to Prepare a interventionnal care study for residents with cancer: Describing cancers management in nursing homes without any oncogeriatrician, Refining the expected effect of an oncogeriatry intervention on QOL (margin of improvement relative to the cancer free population) Estimating the intraclass correlation coefficient of QOL, Compare quality of life scores among seniors with no cognitive impairment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026